Hemp derivatives in France 2026: HHC, H4CBD, HHCPO, legality and risks
Updated on July 30, 2026, by Frédéric Penain (Cloud Store CBD).
Quick Answer: HHC, HHCO, and HHCPO are banned in France
Since the decree of June 11, 2024 (JORF No. 0136 of June 13, 2024), the molecules HHC, HHCO, and HHCPO have been classified as narcotics in France. Selling, possessing, or consuming these derivatives carries the penalties prescribed for narcotics. H4CBD and THCP are not specifically classified as of July 30, 2026, but their status remains legally fragile. Only cannabinoids naturally present in hemp—CBD, CBG, CBN—remain authorized under the 0.3% delta-9 THC threshold.
Since 2022, several hemp derivatives appeared on the French market—HHC, HHCO, HHCPO, H4CBD, THCP—before being banned one after the other. This is one of the major trends in the CBD hemp market in 2026, and hemp news in France evolves several times a year based on ministerial decrees. For those trying to understand, it gives an impression of instability, or even regulatory yo-yoing.
This guide sets the record straight. We will define what a hemp "derivative" really is (as opposed to a natural molecule), retrace the chronology of French bans with official sources, explain why a substance can be tolerated and then banned, and provide a practical framework to avoid being caught by a product with uncertain status.
What is a hemp derivative?
The word "derivative" is ambiguous: in a broad sense, every marketed cannabinoid is derived from hemp. However, in the current debate surrounding HHC or H4CBD, the term specifically refers to semi-synthetic molecules, which are obtained through chemical conversion of a natural cannabinoid (most often CBD) into a new structure rarely present in the plant in its natural state.
Practically, a manufacturer starts with CBD extract, subjects it to a chemical reaction (hydrogenation, isomerization, or esterification, depending on the case), and obtains a different molecule with a more pronounced psychoactive effect. This process distinguishes a semi-synthetic derivative from a naturally extracted molecule. To explore the difference between full spectrum, broad spectrum, and isolate (which are natural extractions without conversion), see our guide on full spectrum, broad spectrum, or isolate.
Why is this distinction critical?
The more a molecule is converted, the more the final quality depends on the manufacturer's reliability: process control, purification, checking reaction by-products, and transparency regarding batch analyses. Well-extracted CBD remains CBD; poorly hydrogenated HHC can contain unwanted residues that there is no requirement to declare.
HHC, HHCO, HHCPO: why are they banned in France?
HHC (hexahydrocannabinol) is a semi-synthetic cannabinoid obtained by the hydrogenation of THC or CBD. Having appeared on the French market in mid-2023, it was classified as a narcotic by the decree of June 11, 2024, along with its derivatives HHCO (acetate) and HHCPO (palmitate). There are three reasons for this rapid ban, and a direct message: do not buy, do not possess, do not consume.
Psychoactive effects similar to, or even stronger than, THC
HHC produces effects similar to delta-9 THC: altered perception, drowsiness, and sometimes anxiety or tachycardia. Esterified derivatives HHCO and HHCPO are reportedly even more potent according to user feedback and analysis by the EUDA (European Union Drugs Agency). These profiles are incompatible with the French 0.3% THC threshold that has governed the marketing of hemp products since the 2022 Council of State ruling.
Virtually no scientific background
HHC has been used by humans on a large scale for less than five years. The long-term profile—tolerance, dependence, drug interactions, cardiovascular effects—is largely unknown. The ANSM and MILDECA have repeatedly warned about this lack of data. When there are neither solid clinical studies nor population-based follow-up, the precautionary principle applies.
Risk of reaction by-products
Hydrogenation (HHC) and esterification (HHCO, HHCPO) produce the target molecule plus, depending on the process, isomers, catalytic residues, and contaminants. A rigorous manufacturer purifies their product; an unreliable manufacturer leaves traces that routine laboratories cannot always detect. For these very new molecules, the market still lacks analytical standards.
Concretely, since June 13, 2024
HHC, HHCO, and HHCPO disappeared from the inventories of reputable shops in the days following publication in the Official Journal No. 0136. If a shop is still offering them in May 2026, they are selling a narcotic. For details on other molecules with uncertain status (H4CBD, THCP, THCH), see the chronology below and the summary table.
Chronology of bans in France (2023-2026)
France reacted in several waves. Each time, the scenario repeated itself: a new molecule arrived on the market, relying on the lack of an explicit classification; health authorities (ANSM, MILDECA) issued alerts, and a ministerial decree eventually classified it as a narcotic.
| Date | Molecule(s) concerned | Regulatory development |
|---|---|---|
| January 24, 2022 | Hemp flowers and leaves | Council of State ruling No. 444887: authorized on the condition of a THC content strictly below 0.3% (Légifrance). |
| Mid-2023 | HHC (hexahydrocannabinol) | Commercial appearance in France. Successive warnings from ANSM and MILDECA regarding the lack of scientific background and the risk of dependence. |
| June 11, 2024 | HHC, HHCO, HHCPO | Decree of June 11, 2024 classifying these three molecules as narcotics. Publication in the Official Journal No. 0136 of June 13, 2024. Sale, possession, and use are prohibited. |
| Summer 2024 - 2025 | H4CBD | Sold as a replacement for HHC in some shops. No nominal classification as a narcotic at this stage, but a precautionary position from MILDECA and high legal uncertainty. |
| 2024 - 2026 | THCP, THCH, other analogues | European monitoring via the EUDA (formerly EMCDDA). Several member states are tightening regulations. In France, legal status is not stabilized. |
Sources: Légifrance (CE ruling 01/24/2022 and decree of June 11, 2024, JORF No. 0136), ANSM, MILDECA, EUDA (European Union Drugs Agency, formerly EMCDDA).
Key Point
As long as you are reading this article, assume that HHC, HHCO, and HHCPO have been strictly prohibited in France since June 13, 2024. Selling, transporting, or consuming these substances exposes you to the penalties prescribed for narcotics. The situation regarding other derivatives (H4CBD, THCP, THCH) can change rapidly: verify the publication date of any information before acting.
How a molecule becomes tolerated and then banned?
The time lag between the commercial appearance of a molecule and its regulatory oversight is not a bug: it is the direct consequence of how European legal systems function. A substance is only banned if it is explicitly listed as a narcotic or refused as a novel food. As long as it is not, some players believe they can market it.
Three typical stages
- Commercial appearance. A new semi-synthetic molecule arrives on the European market, sometimes imported from the United States or countries where regulations are more flexible. It is sold as "legal" on the grounds that it is not listed.
- Analysis phase. National health agencies (ANSM in France) and European agencies (EUDA, formerly EMCDDA) analyze the composition, identify reported adverse effects, and evaluate the risk profile. This phase can last several months.
- Regulation. If the benefit/risk profile is judged unfavorable, the molecule is added to the list of narcotics by ministerial decree. It becomes prohibited for sale, possession, and use. Merchants generally have a few days to remove their stock.
This mechanism explains why a product can be advertised as "legal" one quarter and legally banned the next. This does not mean it was risk-free during the period of tolerance: it simply means that the legislator had not yet made a decision. To understand how this framework relates to the rest of the law on legal CBD in France, read our comprehensive guide Legal CBD in France in 2026.
Practical consequence
Buying a derivative during its window of tolerance is not a free pass. In the event of a roadside check after a rapid classification, residual traces detected can cause problems, as explained by the thresholds detailed in our guide CBD and driving in France.
Natural vs. semi-synthetic: the concrete difference
This opposition is not just a slogan. It corresponds to two production chains, two risk profiles, and two distinct legal regimes.
A) Molecules naturally present in hemp
CBD, CBG, CBN, CBC, and terpenes (myrcene, limonene, pinene, caryophyllene) are synthesized by the plant itself. They are extracted using supercritical CO2, ethanol solvent, or cold pressing. The chemical profile of the final product reflects that of the original flower. The synergy between minor cannabinoids and terpenes, sometimes called the entourage effect, was described by Russo in 2011 in the British Journal of Pharmacology (Russo, 2011).
B) Semi-synthetic derivatives (HHC, H4CBD, HHCPO, THCP)
These molecules do not exist (or only in trace amounts) in the plant. They are obtained through chemical conversion in a laboratory:
- HHC (hexahydrocannabinol): obtained by hydrogenation of THC or CBD. Psychoactive effects similar to THC, sometimes longer in duration.
- HHCO and HHCPO: esterified versions of HHC (acetate, palmitate), reputed to be even more potent.
- H4CBD: hydrogenated version of CBD. Effect described as more relaxing than classic CBD but with a different pharmacological profile.
- THCP (tetrahydrocannabiphorol): present in trace amounts in some varieties but marketed in a synthesized form. Receptor affinity described as significantly higher than that of THC.
Source: European Union Drugs Agency (EUDA), HHC and related cannabinoids - topic overview, updated 2024.
Three practical differences that change everything
- Origin of psychoactivity. Natural molecules exhibit a weak (CBD) to moderate (CBG/CBN) psychotropic effect. Semi-synthetic derivatives can reach or even exceed the profile of THC.
- Reaction by-products. A hydrogenation reaction produces the target molecule plus, sometimes, isomers and catalytic residues. A rigorous manufacturer purifies; a less rigorous one leaves traces.
- Clinical background. CBD has been studied since the 1960s (Mechoulam). HHC or THCP have been used on a large scale by humans for less than five years. The long-term profile remains largely unknown.
These molecules do not appear spontaneously on a flower: they are sprayed onto it using the same equipment used to add CBD isolate. The process is detailed in our guide on boosted CBD flowers.
Why remain cautious regarding derivatives
Variability of real quality
Without a precise certificate of analysis, two products bearing the same name can have very different compositions. Neat packaging is not proof of quality: only a COA from an independent laboratory and batch traceability are. To read a certificate correctly, see our guide full spectrum, broad spectrum, or isolate.
Sometimes unpredictable effects
Semi-synthetic derivatives generate more variable user feedback than classic CBD. For some profiles, this can translate into discomfort (excessive drowsiness, anxiety, occasional tachycardia), especially in case of overdose. At equivalent doses, the effects are not comparable to those of CBD or CBG.
Interactions and risk situations
Like any psychoactive cannabinoid: be careful if you are undergoing treatment (particularly anticoagulants, antiepileptics, immunosuppressants), if you are pregnant or breastfeeding, or if you need to drive. A derivative can generate a residual detectable in a roadside test, with the consequences detailed in our CBD and driving guide.
Personal regulatory risk
Once the classification is published, possessing the product becomes an offense. In practice, there is no grace period for clearing out stocks in private households: what was in your cupboard last night might be a controlled substance this morning. It is better to anticipate by choosing cannabinoids with a stable status.
Field perspective
Over the 18 months between 2023 and 2024, we saw three successive waves on the market: HHC, then H4CBD, then THCP. Each time, the same cycle: aggressive marketing for a few months, a multiplication of consumer complaints, ANSM alert, classification. Cloud Store did not list any of these molecules. The reason is simple: a product that may no longer be sellable in 6 months does not deserve a place in our assortment.
What the 2026 checks found
So far, this article talks about declared molecules: you know what you are buying, the question is whether it is legal. In 2026, a second risk became visible, and it is of a different nature — products sold as CBD that are not.
The mechanism: synthesis sprayed onto flower
The Regional Health Agency (ARS) of La Réunion has been investigating several acute intoxications since 2026 that occurred after consuming products presented as CBD. The molecule identified is MDMB-Pinaca, a synthetic cannabinoid classified as a controlled substance, sprayed onto the flower to enhance its effect. These products were available over-the-counter, notably in gas stations and tobacco shops, sometimes presented as being particularly potent.
This is exactly the technical process described above: spraying. The difference is that here, nothing is disclosed. The consumer thinks they are buying legal hemp; they are buying a controlled substance for which they know neither the molecule nor the dose. The spraying process is detailed in our guide on boosted CBD flowers.
The national signal: about 500 reports
This is not an isolated case overseas. In June 2025, the ANSM and ANSES published a national alert after identifying several hundred intoxications since early 2024 among people who consumed products presented as CBD. Between the beginning of 2025 and April 30, 2026, the ANSM recorded about 500 reports transmitted to the network of centers for evaluation and information on pharmacodependence (CEIP-A).
Source: ANSM, "Increase in intoxications caused by CBD-based products containing other substances." See also the reference page of the ARS Occitanie on the risks associated with the use of cannabidiol.
Among the youngest, the main vector is vaping. In the explanatory statement of an amendment adopted in the Senate in May 2026, the Government reported 345 reports of synthetic cannabinoid vaping in 2025, 71% of which concerned 13-18 year olds. Regarding what the law provides, or does not yet provide, for sales to minors: CBD and minors: what the law says in 2026.
What has changed legally A prefect can now close a shop without a conviction
On May 29, 2026, the prefects of the Eure and Seine-Maritime departments ordered the six-month closure of 13 CBD businesses (5 in Eure, 8 in Seine-Maritime) as part of operations to dismantle drug trafficking. The legal basis is new: Article L. 333-2 of the Internal Security Code, created by the Law of June 13, 2025 aimed at fighting drug trafficking.
The operating companies applied to the interim relief judge to suspend these orders. On July 10, 2026, the Rouen Administrative Court rejected their requests, noting that the prefects were justified by a public interest related to the fight against drug trafficking. The court remains seized of the merits of the appeals and will rule in the coming months on the annulment of the orders.
Source: Rouen Administrative Court, press release on the decisions of July 10, 2026.
What the analyses revealed
The March 2026 raids that preceded these closures give the measure of the problem. Out of 108 products seized, 80% were classified as controlled substances after laboratory analysis, and 73 exceeded the legal threshold of 0.3% THC, up to 1% in some cases. The synthetic molecules identified are CUMYL-PINACA and EDMB-4. About 300,000 euros in cash were also seized. The individuals arrested will appear before the criminal court on October 15, 2026.
Source: ICI Normandie (France 3 / France Bleu), "Discovery of narcotic products: 13 administrative closures of CBD businesses in Eure and Seine-Maritime."
Four products out of five. It's not an isolated shop that bought poorly; it's a network. And the figure says something else: these products were on the shelves, sold to customers who thought they were buying legal hemp.
In concrete terms, for you: the sanction no longer waits for a trial. A shop whose products are sent for analysis and come back classified as controlled substances can be closed for six months by prefectural decision. For the buyer, this means that a store open yesterday might not be open tomorrow — and that the only safety net remains the batch's certificate of analysis.
Three reflexes specific to fake CBD
- A strong effect is not a mark of quality; it is a warning sign. CBD is not psychoactive in the THC sense. A product sold as "very powerful" or "getting you high" is not describing CBD.
- The circuit matters. The reported cases concern products purchased outside specialized channels — gas stations, tobacco shops, informal resale. A seller who cannot produce a COA has nothing to fall back on.
- A COA is not limited to the THC level. Ask for the full list of detected cannabinoids and the analysis method. A panel that only looks for THC and CBD will never find a MDMB-Pinaca.
Summary table: status in France for each derivative
| Molecule | Origin | Status in France 2026 | Cloud Store Recommendation |
|---|---|---|---|
| CBD | Natural (extraction) | Authorized if THC < 0.3% (CE 2022) | Safe choice, see our complete CBD benefits guide |
| CBG | Natural | Authorized (same conditions) | Natural alternative available in assortment |
| CBN | Natural (from THC oxidation) | Authorized (same conditions) | Natural alternative for the night profile |
| HHC | Semi-synthetic (hydrogenation) | Controlled substance since 06/13/2024 | Forbidden, do not buy or possess |
| HHCO / HHCPO | Semi-synthetic (HHC esterification) | Controlled substances since 06/13/2024 | Forbidden, do not buy or possess |
| H4CBD | Semi-synthetic (CBD hydrogenation) | Fragile legal status, risky sale | Avoid, Cloud Store prudential position |
| THCP / THCH | Natural in trace amounts, sold synthesized | EUDA surveillance, status not stabilized | Avoid, Cloud Store prudential position |
Status as of July 30, 2026. Source: Légifrance (decree of June 11, 2024), MILDECA, ANSM, EUDA. Regulations can evolve; check the date of any source before purchasing.
Checklist: 7 reflexes to choose a compliant product
The 7 reflexes that avoid 90% of bad surprises
- Require a recent certificate of analysis (COA) indicating the batch, date, and independent laboratory.
- Verify compliance with delta-9 THC < 0.3% on the COA, not just on the packaging.
- Read the list of detected cannabinoids: if you see HHC, HHCO, HHCPO, run away (these molecules are forbidden in France).
- Beware of ambiguous commercial promises: "stronger than CBD," "guaranteed effect," "new legal molecule" are warning signs.
- Prioritize full traceability: variety, origin, cultivation method, country of extraction, batch.
- For a first try, start with a minimal dose and observe before readjusting, ideally with a flower, resin, or oil with a natural CBD/CBG/CBN profile, see our tips for choosing your CBD flower.
- Prefer a transparent and reachable actor with a French address, clear general terms and conditions, and identifiable customer service.
Why Cloud Store does not offer these molecules
The position is simple and has not changed since our opening: Cloud Store only lists cannabinoids naturally present in European legal hemp and compliant with the French threshold of 0.3% THC. No HHC, no H4CBD, no HHCPO, no THCP, no semi-synthetic cannabinoid of any kind.
Three reasons for this:
- Legal stability. A shop that lists a molecule with an uncertain status can be forced to withdraw its stock overnight. It is a risk for us and a risk for you.
- Controllable quality. Well-extracted CBD or CBG is fully analyzable. A semi-synthetic derivative requires more advanced checks that routine laboratories cannot always perform.
- Customer consistency. The feedback we have had over three years points to a clear expectation: hemp, natural, legal, traceable. Seeking semi-synthetic novelties is not meeting that expectation.
Discover our selection of CBD flowers, resins, and oils compliant with the French framework, supported by laboratory analyses.
See our CBD flowersFAQ — Hemp derivatives and legality in France
Is HHC still legal in France in 2026?
No. HHC, as well as its derivatives HHCO and HHCPO, were classified as controlled substances by the decree of June 11, 2024, published in the Official Journal No. 0136 on June 13, 2024. Selling, possessing, transporting, or consuming these molecules has been forbidden in France since that date, with the sanctions provided for narcotics.
Is H4CBD legal in France?
As of July 30, 2026, H4CBD is not explicitly classified as a controlled substance in France. However, it is a semi-synthetic derivative obtained by hydrogenation of CBD, the status of which is legally fragile: MILDECA and ANSM have issued prudential positions. The situation can change rapidly as it did for HHC. Cloud Store does not offer H4CBD.
Why do some shops still sell these products?
For molecules already classified as controlled substances (HHC, HHCO, HHCPO), selling is purely and simply illegal: these shops expose themselves to the corresponding penalties. For molecules with an unstabilized status (H4CBD, THCP), some actors believe they can continue in the silence of the text. This is neither our interpretation nor a signal of trust for the consumer.
"Derived from hemp" mean the product is natural?
Not necessarily. The mention "derived from hemp" can designate either a natural cannabinoid directly extracted (CBD, CBG, CBN), or a semi-synthetic derivative manufactured from a hemp cannabinoid by chemical conversion. Only a precise reading of the certificate of analysis makes it possible to decide.
Which cannabinoids remain authorized in France in 2026?
Cannabinoids naturally present in hemp compliant with the 0.3% delta-9 THC threshold remain authorized: CBD, CBG, CBN, CBC, as well as the associated terpenes. This authorization stems from the Council of State's decision of January 24, 2022 (No. 444887). Flowers, resins, and oils respecting this framework are marketable.
How to verify that a product does not contain a forbidden derivative?
Ask for the certificate of analysis (COA) of the purchased batch. On this document, the list of detected cannabinoids must appear clearly. If you see HHC, HHCO, or HHCPO, the product is forbidden in France and should not be marketed. If the list mentions CBD, CBG, CBN with THC under 0.3%, the profile is compliant. In case of doubt, contact the seller and specifically ask for the analysis methods used.
What does a consumer risk who possesses a forbidden product purchased when it was tolerated?
Strictly speaking, since the classification as a controlled substance, possession is an offense, regardless of the purchase date. In practice, authorities have so far focused their action on merchants rather than on good-faith individuals. The most prudent reflex remains to stop using the product and not to transport it, especially when traveling abroad.
Why does Cloud Store not list any of these derivatives?
Three reasons: legal stability (a product that can become illegal in a few months has no place in an assortment), controllable quality (semi-synthetic derivatives require more advanced analyses), and consistency with what customers expect from French legal hemp: natural, traceable, compliant. Our catalog is limited to cannabinoids naturally present in compliant hemp.
How do I know if my CBD contains a synthetic cannabinoid?
A batch certificate of analysis is the only reliable way, provided it lists all the cannabinoids sought and not just THC and CBD. The signals that should alert you: a clearly psychoactive effect, a product sold as "very powerful," a non-specialized sales circuit (gas station, tobacco shop), the absence of a COA. If you feel unwell after consumption, contact 15 or a poison control center.
Can a shop close without having been convicted?
Yes, since the law of June 13, 2025, against drug trafficking, which created Article L. 333-2 of the Internal Security Code. A prefect can order the administrative closure of a business for six months. On July 10, 2026, the Rouen Administrative Court rejected the injunctions from 13 shops in Eure and Seine-Maritime closed on this basis on May 29, 2026. The merits appeals remain pending.